Flu vaccines: Flucelvax Quadrivalent, 1st cell-based 4-strain flu vaccine, gets FDA nod

Seqirus announced this week that the US Food and Drug Administration (FDA) has approved FLUCELVAX QUADRIVALENTa (Influenza Vaccine), the first four-strain, cell culture-derived, inactivated seasonal influenza vaccine for people aged four years and older. FLUCELVAX QUADRIVALENT helps protect against the two influenza A viruses and two B viruses recommended by the World Health Organization (WHO) and the ["]